Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lauren Hodsdon"'
Autor:
Jarrod T. Smith, BA, Aneri Balar, MD, Dhairya A. Lakhani, MD, Christien Kluwe, MD, PhD, Zhiguo Zhao, MS, Prasad Kopparapu, PhD, Karinna Almodovar, PhD, Anel Muterspaugh, MPH, CPH, Yingjun Yan, MS, Sally York, MD, PhD, Leora Horn, MD, MSc, Sanja Antic, MS, Caterina Bertucci, MPA, Tristan Shaffer, MS, Lauren Hodsdon, MPH, Kavita Garg, PhD, Seyed Ali Hosseini, MD, PhD, Lee Lim, PhD, Evan Osmundson, MD, PhD, Pierre P. Massion, MD, Christine M. Lovly, MD, PhD, Wade Iams, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 3, Pp 100110- (2021)
Introduction: Blood-based next-generation sequencing assays of circulating tumor DNA (ctDNA) have the ability to detect tumor-associated mutations in patients with SCLC. We sought to characterize the relationship between ctDNA mean variant allele fre
Externí odkaz:
https://doaj.org/article/30a2425056284f07b711aa00850a555d
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 5, Pp 1179-1187 (2018)
Background. In 2013, the US Advisory Committee on Immunization Practices (ACIP) opted against adding meningococcal vaccines to the infant schedule due to poor cost-effectiveness. This raises a policy question: if meningococcal disease is too rare to
Externí odkaz:
https://doaj.org/article/4893ebd560ad4395b52de624a762428f
Autor:
Prasad R. Kopparapu, Tristan Shaffer, Anel Muterspaugh, Christopher G. Cann, Kenneth Wyman, Lauren Hodsdon, Heidi Chen, Wade T. Iams, Zhiguo Zhao, Yingjun Yan, Sally York, Leora Horn, Lee P. Lim, Kavita Garg, Christine M. Lovly, Kristin K. Ancell, Seyed Ali Hosseini, Caterina Bertucci
Publikováno v:
JTO Clinical and Research Reports, Vol 1, Iss 2, Pp 100024-(2020)
JTO Clinical and Research Reports
JTO Clinical and Research Reports
Introduction Most patients (70%) with limited-stage SCLC (LS-SCLC) who are treated with curative-intent therapy suffer disease relapse and cancer-related death. We evaluated circulating tumor DNA (ctDNA) as a predictor of disease relapse and death af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e19cbe9ad4d13d8542e46b7acf0c68cd
http://www.sciencedirect.com/science/article/pii/S2666364320300242
http://www.sciencedirect.com/science/article/pii/S2666364320300242
Autor:
Dhairya A. Lakhani, Wade T. Iams, Karinna Almodovar, Christien Kluwe, Aneri B. Balar, Evan C. Osmundson, Leora Horn, S. Antic, Prasad R. Kopparapu, Anel Muterspaugh, Jarrod T. Smith, Zhiguo Zhao, Seyed Ali Hosseini, Lauren Hodsdon, Lee Lim, Christine M. Lovly, Caterina Bertucci, Pierre P. Massion, Kavita Garg, Yingjun Yan, Sally York, Tristan Shaffer
Publikováno v:
JTO Clinical and Research Reports
JTO Clinical and Research Reports, Vol 2, Iss 3, Pp 100110-(2021)
JTO Clinical and Research Reports, Vol 2, Iss 3, Pp 100110-(2021)
Introduction: Blood-based next-generation sequencing assays of circulating tumor DNA (ctDNA) have the ability to detect tumor-associated mutations in patients with SCLC. We sought to characterize the relationship between ctDNA mean variant allele fre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f959ac8ac1eedf959c4b9ef743d398a
https://pubmed.ncbi.nlm.nih.gov/34589992
https://pubmed.ncbi.nlm.nih.gov/34589992
Autor:
Pierre P. Massion, Tristan Shaffer, Prasad R. Kopparapu, Jarrod T. Smith, Evan C. Osmundson, Yingjun Yan, Sally York, Dhairya A. Lakhani, Kavita Garg, Christine M. Lovly, Zhiguo Zhao, Christien Kluwe, Sanja L. Antic, Lee Lim, Caterina Bertucci, Aneri B. Balar, Leora Horn, Wade T. Iams, Seyed Ali Hosseini, Anel Muterspaugh, Lauren Hodsdon, Karinna Almodovar
Publikováno v:
Cancer Research. 80:715-715
Introduction Blood-based next generation sequencing assays of circulating tumor DNA (ctDNA) have the ability to detect canonical SCLC tumor-associated mutations1,2. In non-small cell lung cancer, mean variant allele frequency (VAF) of clonal mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fabe505148ccd565004c930b2da9120
https://doi.org/10.1158/1538-7445.am2020-715
https://doi.org/10.1158/1538-7445.am2020-715
Publikováno v:
Human Vaccines & Immunotherapeutics
Background. In 2013, the US Advisory Committee on Immunization Practices (ACIP) opted against adding meningococcal vaccines to the infant schedule due to poor cost-effectiveness. This raises a policy question: if meningococcal disease is too rare to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13271e0edc345e72f04465c2138972c2
https://pubmed.ncbi.nlm.nih.gov/28509601
https://pubmed.ncbi.nlm.nih.gov/28509601